Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

Towards the development of chemotherapy for the infection by human T-cell leukemia virus type I (HTLV-I), we have established evaluation systems for HTLV-I protease (PR) inhibitors using both recombinant and chemically synthesized HTLV-I PRs. Newly synthesized substrate-based inhibitors containing hydroxymethylcarbonyl (HMC) isostere showed potent anti-HTLV-I PR activity.

Knowledge Graph

Similar Paper

Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic
Bioorganic & Medicinal Chemistry Letters 2004.0
Identification of constrained peptidomimetic chemotypes as HIV protease inhibitors
European Journal of Medicinal Chemistry 2014.0
Reduction of Peptide Character of HIV Protease Inhibitors That Exhibit Nanomolar Potency against Multidrug Resistant HIV-1 Strains
Journal of Medicinal Chemistry 2003.0
Synthesis and evaluation of pyridyl analogs of L-735,524: Potent HIV-1 protease inhibitors
Bioorganic & Medicinal Chemistry Letters 1994.0
Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary-Alcohol-Containing Transition-State Mimic
Journal of Medicinal Chemistry 2008.0
HIV-1 Protease Inhibitors with a Transition-State Mimic Comprising a Tertiary Alcohol: Improved Antiviral Activity in Cells
Journal of Medicinal Chemistry 2010.0
Inorganic Polyhedral Metallacarborane Inhibitors of HIV Protease: A New Approach to Overcoming Antiviral Resistance
Journal of Medicinal Chemistry 2008.0
Synthesis, Stability, Antiviral Activity, and Protease-Bound Structures of Substrate-Mimicking Constrained Macrocyclic Inhibitors of HIV-1 Protease
Journal of Medicinal Chemistry 2000.0
Novel pseudosymmetric inhibitors of HIV-1 protease
Bioorganic & Medicinal Chemistry Letters 1993.0
Structural Basis for HTLV-1 Protease Inhibition by the HIV-1 Protease Inhibitor Indinavir
Journal of Medicinal Chemistry 2014.0